The ibuprofen API market is influenced by several factors such as medical regulations, patent expiry, market demand, and technological advancements. Ibuprofen is a widely used nonsteroidal anti-inflammatory drug (NSAID) known for its analgesic, anti-inflammatory, and antipyretic properties. It is often used to treat a variety of conditions such as headaches, arthritis, menstrual pain, and minor injuries.
NEWARK, Del., April 4, 2024 (Globe Newswire) — According to Future Market Insights’ recently proposed market analysis for ibuprofen API, global demand for ibuprofen API in 2024 will be approximately USD 665 million.is predicted to record a CAGR of 2.5% and reach USD 851 million The evolving scenario of emerging economies, increasing production of pharmaceuticals and biopharmaceuticals, and increasing geriatric population are primarily driving the market growth in the API sector.
Ibuprofen, a nonsteroidal anti-inflammatory drug, is used to treat menstrual discomfort, particularly dysmenorrhea, which affects approximately 1.8 billion people worldwide. Made from active pharmaceutical ingredients such as analgesics, antipyretics, and anti-inflammatory agents, APIs reduce pain, fever, and inflammation. These drugs are often used to reduce menstrual discomfort by blocking prostaglandins.
Get an exclusive sample copy of the report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11260
The growing number of chronic diseases in developing countries has increased the demand for ibuprofen API. Pharmaceutical and biochemical organizations are investing in research and development of the drug, which is available in tablets, capsules, and syrup. Elderly patients use this drug to relieve pain, lower fever, and reduce inflammation. Biopharmaceutical companies are developing ibuprofen API supplements to treat illnesses such as upset stomachs, gastrointestinal bleeding, and kidney damage. Various synthetic routes to ibuprofen are being developed to drive market growth and provide optimism for the ibuprofen raw material market.
Ibuprofen API synthesis is facing environmental challenges due to revised manufacturing guidelines, impacting manufacturers’ costs and raw material sourcing. The drug requires high production values, which has led to a weak market. Leading pharmaceutical and medical manufacturers are exploring environmentally friendly synthetic ibuprofen APIs, with the opportunity to grow demand through bioinformatics, high-throughput methods, and combinatorial chemistry. Market players must be cautious and flexible to succeed in the industry.
Key Takeaways from Ibuprofen API Market Report
-
The Canadian Ibuprofen API industry is projected to witness a CAGR of 2.0% by 2034.
-
The German ibuprofen API market is estimated to exhibit a CAGR of 2.7% by 2034.
-
The Italian Ibuprofen API industry is expected to grow at a CAGR of 3.3% from 2024 to 2034.
-
Spain’s ibuprofen API sector is projected to exhibit a CAGR of 3.7% until 2034.
-
The French ibuprofen API market is expected to exhibit a CAGR of 3.0% by 2034.
“Chronic diseases in emerging countries are fueling market expansion for the drug substance industry, driven by demand for ibuprofen drug substance.Pharmaceutical and biopharmaceutical companies are looking to treat gastrointestinal bleeding, kidney damage, and stomach upset. However, environmental concerns associated with new production requirements are shrinking the market. Important pharmaceutical and medical companies are researching environmentally friendly synthetic ibuprofen APIs and Demand is likely to increase through chemistry, high-throughput technologies, and bioinformatics. Market participants will need to be careful and adapt to thrive in this environment.” To tell Sabasachi Ghosh (Vice President, Future Market Insights, Inc.)
How to request a report:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-11260
Competitive landscape of Ibuprofen API market
Suppliers of pharmaceutical raw materials work with CMOs to increase raw material availability and optimize production procedures, resulting in economic and temporary benefits. The pharmaceutical API industry is experiencing a surge in mergers and acquisitions due to global market expansion, pipeline development, and therapeutic drug-related objectives. Specifically, these tactics increase productivity in product development by reducing expenses and creating economies of scale. To achieve long-term success, expanding market share and attracting new customers is also important and has become a key strategy in the Ibuprofen API market.
Recent trends in the Ibuprofen API market
BioSyent Pharma Inc. shipped the first fixed-dose combination of acetaminophen and ibuprofen in one tablet in Canada in December 2020 for short-term pain relief and fever management.
Major companies
-
BASF SE
-
Biocourse Co., Ltd.
-
IOL Chemicals and Pharmaceuticals Limited
-
SI Group Co., Ltd.
-
Central America Zibo Xinhua Perrigo Pharmaceutical Co., Ltd.
-
Solara Active Pharma Sciences Limited
-
Granules India Ltd.
Purchase this exclusive report:
https://www.futuremarketinsights.com/checkout/11260
Major segments
By end user:
By region:
-
North America
-
latin america
-
Europe
-
east asia
-
south asia
-
Oceania
-
middle east and africa
author:
Sabyasachi Ghosh (Vice President, Future Market Insights, Inc.) has over 12 years of experience in the healthcare, medical device, and pharmaceutical industries. His curiosity and analytical skills helped shape his career as a researcher.
It comes naturally to him to identify the key challenges faced by his clients and develop robust, hypothesis-based solutions to empower them with strategic decision-making capabilities. His main expertise lies in the areas of market entry and expansion strategies, feasibility studies, competitive intelligence, and strategic transformation.
Sabyasachi, who holds a degree in microbiology, has written numerous publications and has been cited in journals such as The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s relevant and ongoing coverage of the Healthcare Market Insights domain.
-
Oligonucleotide API Market: Owing to the growing need for new drug classes, the demand for oligonucleotide APIs is projected to increase at a high CAGR of 5.60% from 2024 to 2034. Therefore, the global oligonucleotide API market is expected to increase from its valuation. In 2024, it will be 2.81 billion USD, and by the end of 2034, it will be 4.84 billion USD.
-
Small Molecule API Market: Small molecule API market revenue is expected to reach USD 174 billion by 2033. His CAGR for the small molecule API market during the forecast period is expected to be 4.1%.
-
Antibiotic Active Pharmaceutical Ingredients (API) Market: The global antibiotic active pharmaceutical ingredient (API) market is expected to reach USD 12,002.3 million by 2033, registering a CAGR of 3.3% during the forecast period .
-
Healthcare API Market: The global healthcare API market is USD 316.2 million It is predicted to increase by 2033 and further expand at a CAGR of 100%. 3.6% reach the valuation of USD 316.2 million By 2033.
-
Cancer Tissue Diagnostics Market Demand: The cancer tissue diagnostics market is showing an upward trend and its value is estimated to reach USD 23,516.2 million in 2034 from USD 15,302.2 million in 2024. The introduction of cancer tissue diagnosis has shown a CAGR of 4.5. % from 2024 to 2034.
-
Therapeutic Nuclear Medicine Market Trends: The therapeutic nuclear medicine market is projected to register a CAGR of 4.10% from 2024 to 2034, with a market valuation of USD 1.32 billion in 2024. Due to the development of demand, the valuation is set at USD 1.97 billion. It will be launched on the market in 2034.
-
Specialty Pharmaceutical Ingredients Market: The demand for specialty pharmaceutical ingredients is expected to increase at a CAGR of 3.2% during the forecast period. The market value of specialty pharmaceutical active ingredients (APIs) is expected to reach USD 282.88 billion by 2033.
-
Cataract Surgery Devices Market Opportunities: The cataract surgery devices market is showing an upward trend and its value is estimated to reach USD 12,472.7 million in 2034 from USD 8,928 million in 2024. The adoption of cataract surgery devices has shown a tremendous growth rate. 3.40% from 2024 to 2034.
-
Livestock Vaccines Market Outlook: The livestock vaccines market was valued at USD 6.1 billion in 2024 and is projected to increase to USD 11.2 billion by 2034. The market is expected to grow at a CAGR of 6.2% during the forecast period.
-
Anti-Aging Products Services and Devices Market Strategy: According to FMI’s revised market report, anti-aging products services and devices sales will reach USD 60,764.4 million in 2024 at current valuation. Following this trend, this market for anti-aging products services is expected to expand to represent a market of USD 101,843.4 million, at a steady CAGR of 5.30% by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR Certified, Stevie Award Winner, Greater New York Chamber of Commerce Member) provides deep insight into the drivers driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting, and events for the packaging, food and beverage, consumer technology, healthcare, industrial, and chemical markets. With a large team of over 400 analysts located around the world, FMI provides global, regional and local expertise on diverse sectors and industry trends in over 110 countries.
inquiry:
Nandini Singh Sawarani
Future Market Insights Co., Ltd.
Christiana Corporate, 200 Continental Drive;
Suite 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
Sales inquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blog | YouTube
